Edition:
United Kingdom

People: Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

562.35INR
23 May 2019
Change (% chg)

-- (--)
Prev Close
Rs562.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
604,309
52-wk High
Rs711.90
52-wk Low
Rs505.50

Mani, V. S. 

Mr. V. S. Mani serves as Global Chief Financial Officer, Executive Director of the Company. Mr. Mani leads the organisation’s worldwide finance operations and secretarial function, including global accounting, financial reporting, tax and treasury. He has over 25 years of rich industry experience across treasury, taxation, accounting, financial planning & analysis, secretarial, legal, audits, risk management and investor relations. Prior to joining Glenmark in 2017, he was the President Finance at the Bhartiya Group. He has also held the position of the Chief Financial Officer at Cipla.

Basic Compensation

Total Annual Compensation, INR 12,900,000
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR 8,240,000
Fiscal Year Total, INR 21,140,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Glenn Saldanha

161,620,000

V. S. Mani

21,140,000

Harish Kuber

2,750,000

Cherylann Pinto

42,940,000

Rajesh Desai

1,200,000

Blanche Saldanha

400,000
As Of  31 Mar 2018